News
News releases on January 10, 2022, page 4
Every news release public companies put out on January 10, 2022 (UTC): 517 news releases, newest first. Open any release to read it.
MKS Instruments Announces Fourth Quarter and Full Year 2021 Earnings Conference Call
MKS Inc. · Jan 10, 2022
MIMEDX Outlines Key Strategic Milestones for 2022
MiMedx Group, Inc · Jan 10, 2022
Microvast and FPT Industrial Under the Hood of the New IVECO BUS Electric Crossway
Microvast Holdings, Inc. · Jan 10, 2022
Micron Technologies Sympathizes with the Worldwide Wave of the Omicron Covid Variant and Offers Medical Grade Face Masks
Micron Technology, Inc. · Jan 10, 2022
Micron Announces CFO Transition
Micron Technology, Inc. · Jan 10, 2022
MEDIA ALERT: Equinix Sets Conference Call for Fourth Quarter and Full Year Results
Equinix, Inc. · Jan 10, 2022
Matthews International Announces First Quarter Fiscal 2022 Earnings Release and Conference Call
Matthews International Corporation · Jan 10, 2022
MarketAxess to Host Conference Call Announcing Fourth Quarter 2021 and Full Year 2021 Results on Wednesday, January 26, 2022
MarketAxess Holdings, Inc. · Jan 10, 2022
Marchex to Present at the 2022 Needham Virtual Growth Conference
Marchex, Inc. · Jan 10, 2022
Manhattan Associates Announces Date for Reporting Fourth Quarter 2021 Financial Results
Manhattan Associates, Inc. · Jan 10, 2022
Majestic Gold Announces Update to Normal Course Issuer Bid
Majestic Gold Corp. · Jan 10, 2022
Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for 2022
Dianthus Therapeutics, Inc. · Jan 10, 2022
Lupaka Gold Acquires Three Potential Gold Properties in Oregon, USA
Lupaka Gold Corp. · Jan 10, 2022
Loop Industries to Hold Q3 2022 Corporate Update Call January 12, 2022 at 11: 00 AM ET
Loop Industries, Inc. · Jan 10, 2022
Liquidity Services Retains Three Part Advisors for Investor Relations Services
Liquidity Services, Inc. · Jan 10, 2022
Lincoln Electric Schedules Webcast for Fourth Quarter and Full Year 2021 Results
Lincoln Electric Holdings, Inc. · Jan 10, 2022
Limoneira Company Announces Fiscal Fourth Quarter and Full Year 2021 Financial Results
Limoneira Co · Jan 10, 2022
LendingTree, Inc. to Host Virtual Analyst and Investor Event on February 02, 2022
LendingTree, Inc. · Jan 10, 2022
Leading Mobile Operator in Mexico Extends 4G Cellular Backhaul Recurring Revenue Managed Services Project with Gilat
Gilat Satellite Networks Ltd. · Jan 10, 2022
Kymera Therapeutics Announces Key 2022 Goals and Milestones to Support Its Evolution into a Fully Integrated Degrader Medicines Company
Kymera Therapeutics, Inc. · Jan 10, 2022
Kiniksa Provides Corporate Update and Outlines Anticipated 2022 Milestones
Kiniksa Pharmaceuticals International, plc · Jan 10, 2022
Karyopharm Promotes Sohanya Cheng to Chief Commercial Officer
Karyopharm Therapeutics Inc. · Jan 10, 2022
Karyopharm Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Net Product Revenues and Outlines 2022 Objectives
Karyopharm Therapeutics Inc. · Jan 10, 2022
Kandi Enters Framework Agreement to Produce Battery Swap-Enabled Electric Vehicles
Kandi Technologies Group, Inc. · Jan 10, 2022
Jowell Global Announces Strategic Partnership with China Ants Alliance
Jowell Global Ltd. · Jan 10, 2022
JetBlue Promotes Lisa Reifer to Head of Finance and Treasury
JetBlue Airways Corporation · Jan 10, 2022
Jesse Watters Named Permanent Host of FOX News Channel’s 7PM Hour
Fox Corporation · Jan 10, 2022
Jazz Pharmaceuticals Announces Vision 2025 to Deliver Sustainable Growth and Enhanced Value to Drive Transformation to Innovative, Global...
Jazz Pharmaceuticals plc · Jan 10, 2022
IZEA Announces Best Q4 Managed ServicesBookings in Company History
IZEA Worldwide, Inc. · Jan 10, 2022
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
Ironwood Pharmaceuticals, Inc. · Jan 10, 2022
iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update
iRhythm Holdings, Inc. · Jan 10, 2022
Iovance Biotherapeutics Announces Raj K. Puri, M.D., Ph.D. to Join Leadership Team
Iovance Biotherapeutics, Inc. · Jan 10, 2022
Investor and Analyst Event: Exelon Details Strategy for Nation’s Largest Fully Regulated Utility Company
Exelon Corporation · Jan 10, 2022
InterDigital Extends Term of Joint Venture and Renews Patent License Agreement with Sony Corporation of America
InterDigital, Inc. · Jan 10, 2022
Intel Names Michelle Johnston Holthaus Executive Vice President and General Manager of Client Computing Business
Intel Corporation · Jan 10, 2022
Intel Names David Zinsner Executive Vice President and Chief Financial Officer
Intel Corporation · Jan 10, 2022
Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC
Inotiv, Inc. · Jan 10, 2022
Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results
Inogen, Inc · Jan 10, 2022
Innodata to Reiterate Growth Outlook at 24th Annual Needham Growth Conference Today
Innodata Inc. · Jan 10, 2022
InflaRx Announces New Pipeline Program – Oral C5aR Inhibitor
InflaRx N.V. · Jan 10, 2022
Impinj Announces Preliminary Fourth-Quarter 2021 Revenue Ahead of Participation at 24th Annual Needham Virtual Growth Conference
Impinj, Inc. · Jan 10, 2022
Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19
Immunome, Inc. · Jan 10, 2022
Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care
Illumina, Inc. · Jan 10, 2022
Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J....
Illumina, Inc. · Jan 10, 2022
Illumina collaborates with Nashville Biosciences to accelerate medicines development
Illumina, Inc. · Jan 10, 2022
Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
Illumina, Inc. · Jan 10, 2022
IDEAYA Biosciences Announces Corporate and Portfolio Update for J.P. Morgan 40th Annual Healthcare Conference
IDEAYA Biosciences, Inc. · Jan 10, 2022
Iconic Peter Luger Steak House to Open Las Vegas Location at Caesars Palace
Caesars Entertainment, Inc. · Jan 10, 2022
Hyperfine Reports Preliminary Unaudited 2021 Revenue and Swoop® System Installations
Hyperfine, Inc. · Jan 10, 2022
Honeywell ultra low-global-warming-potential technology powers new cooling system at the Eiffel Tower
Honeywell International Inc. · Jan 10, 2022
HireQuest, Inc. Announces Acquisition of dmDickason’s Staffing Division
HireQuest, Inc. · Jan 10, 2022
Hawkmoon Resources 2022 Letter to Stakeholders
Earthwise Minerals Corp · Jan 10, 2022
Hasbro to Webcast Fourth Quarter and Full Year 2021 Earnings Conference Call
Hasbro, Inc. · Jan 10, 2022
Harrow Health to Participate in H.C. Wainwright BioConnect Conference
Harrow, Inc. · Jan 10, 2022
Halozyme provides 2022 financial guidance and outlook
Halozyme Therapeutics, Inc. · Jan 10, 2022
Greenland Resources Announces AGM Voting Results
Greenland Resources Inc. · Jan 10, 2022
Goodyear names Christian Gadzinski senior director of investor relations
The Goodyear Tire & Rubber Company · Jan 10, 2022
Golub Capital BDC, Inc. announces $867.7 million in new middle-market originations for its fiscal year 2022 first quarter
Golub Capital BDC, Inc. · Jan 10, 2022
Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic No...
Gilead Sciences, Inc. · Jan 10, 2022
Gibraltar to Present at CJS Securities 22nd Annual New Ideas for the New Year Conference
Gibraltar Industries, Inc. · Jan 10, 2022
Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer
Genprex, Inc. · Jan 10, 2022
Gemini Therapeutics Provides GEM103 Program Update
Disc Medicine, Inc. · Jan 10, 2022
Galmed announces positive results of Phase 1 study of Amilo-5MER
Galmed Pharmaceuticals Ltd. · Jan 10, 2022
Galantas Gold Provides Corporate Update and Production Guidance
Galantas Gold Corporation · Jan 10, 2022
G2 Goldfields Confirms Excellent Gold Recoveries from OKO BLEG Tests
G2 Goldfields, Inc. · Jan 10, 2022
Fulcrum Therapeutics® Announces Upcoming Milestones to Support Its Mission of Treating the Root Cause of Rare Genetic Diseases
Fulcrum Therapeutics, Inc. · Jan 10, 2022
Freshpet, Inc. Provides Preliminary Fourth Quarter Net Sales
Freshpet, Inc. · Jan 10, 2022
Fortress Transportation and Infrastructure Investors LLC to Participate in the Cowen 43rd Annual Aerospace/Defense & Industrials Virtual ...
FTAI Aviation Ltd. · Jan 10, 2022
Five Star Bancorp Announces 4th Quarter 2021 Earnings Release Date and Webcast
Five Star Bancorp · Jan 10, 2022
Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 1, 2022
Five Below, Inc. · Jan 10, 2022
First Watch Restaurant Group, Inc. Announces Preliminary Operational Metrics
First Watch Restaurant Group, Inc. · Jan 10, 2022
First Financial Bancorp to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, January 27, 2022
First Financial Bancorp. · Jan 10, 2022
First Energy Metals Provides Update On Phase 2 Drill Program At Augustus Lithium Property
Linear Minerals Corp. · Jan 10, 2022
Fathom Nickel Announces Results of the Q3-2021 Drill Program and Commencement of the Q1-2022 Drill Program at the Albert Lake Property
Fathom Nickel, Inc. · Jan 10, 2022
Fate Therapeutics Announces FDA Clearance for FT536, a First-in-class MICA/B-targeted CAR NK Cell Product Candidate for the Treatment of ...
Fate Therapeutics, Inc. · Jan 10, 2022
F5 Adds Microsoft’s James Phillips to Board of Directors
F5, Inc. · Jan 10, 2022
EyePoint Pharmaceuticals Appoints Michael C. Pine as Chief Corporate Development and Strategy Officer
EyePoint, Inc. · Jan 10, 2022
EyePoint Pharmaceuticals Announces 2022 Clinical Plans and Highlights Recent Corporate and Clinical Achievements
EyePoint, Inc. · Jan 10, 2022
Extreme Networks Transforms Borås Stad Into Smart City
Extreme Networks, Inc. · Jan 10, 2022
Exponent to Announce Fourth Quarter and Fiscal Year 2021 Results and Host Quarterly Conference Call on February 3, 2022
Exponent, Inc. · Jan 10, 2022
Evolv Technology to Release Fourth Quarter Financial Results on March 14, 2022
Evolv Technologies Holdings, Inc. · Jan 10, 2022
European Wax Center, Inc. Provides Update Ahead of Presentation at ICR Conference
European Wax Center, Inc. · Jan 10, 2022
Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
Establishment Labs Holdings Inc. · Jan 10, 2022
Erdene Resource Development Receives Tax Stabilization Certificate for Bayan Khundii Gold Project
Erdene Resource Development Corporation · Jan 10, 2022
Equillium Announces Multiple Abstracts Accepted for Presentation at the Transplantation & Cellular Meetings of ASTCT and CIBMTR
Equillium, Inc. · Jan 10, 2022
Entel Peru Launches Allot Security-as-a-Service Solution to Protect Mobile Users from Cyberattacks
Allot Ltd. · Jan 10, 2022
Ensysce Biosciences Announces First Cohort Dosing in Bioequivalence (BE) Study of Novel “TAAP” Opioid
Ensysce Biosciences, Inc. · Jan 10, 2022
Enphase Energy Expands Battery Storage in New York
Enphase Energy, Inc. · Jan 10, 2022
Emerita Resources Reports the Environment Department in Huelva Province Has Published a Resolution Approving Drilling the West Side of th...
Emerita Resources Corp. · Jan 10, 2022
electroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Mig...
electroCore, Inc. · Jan 10, 2022
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
Ekso Bionics Holdings, Inc. · Jan 10, 2022
Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference
Editas Medicine, Inc. · Jan 10, 2022
Duluth Holdings Inc. Announces Strong Holiday Results
Duluth Holdings Inc. · Jan 10, 2022
Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer
Madrigal Pharmaceuticals, Inc. · Jan 10, 2022
Diamondback Energy, Inc. Schedules Fourth Quarter 2021 Conference Call for February 23, 2022
Diamondback Energy, Inc. · Jan 10, 2022
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial
DexCom, Inc. · Jan 10, 2022
Denali Therapeutics Announces Progression and Expansion of Broad Therapeutic Portfolio for Neurodegeneration and Expected Key Milestones ...
Denali Therapeutics Inc. · Jan 10, 2022
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
CVRx, Inc. · Jan 10, 2022
Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment
Cullinan Therapeutics, Inc. · Jan 10, 2022
CSG Appoints Rasmani Bhattacharya as General Counsel
CSG Systems International, Inc. · Jan 10, 2022